On October 17, 2022 Alligator Bioscience AB (Nasdaq Stockholm: ATORX) reported that it will host a conference call (in English) for investors, analysts and media on Thursday, October 20, 2022, at 15:00 CET / 9:00 am ET (Press release, Alligator Bioscience, OCT 17, 2022, View Source [SID1234622048]). Alligator will publish the company’s interim report on Thursday, October 20, 2022, at 8:00 CET / 2:00 am ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

CEO Søren Bregenholt and CFO Marie Svensson will present the interim report for the period January – September 2022 followed by a Q&A session.

The conference call will be broadcast live on the web and can be accessed via the link:

The information was submitted for publication, through the agency of the contact person set out below, at 08:30 a.m. CET on October 17, 2022.